Pembrolizumab plus pemetrexed‐platinum for metastatic nonsquamous non–small‐cell lung cancer: KEYNOTE‐189 Japan Study

por Horinouchi, Hidehito, Nogami, Naoyuki, Saka, Hideo, Nishio, Makoto, Tokito, Takaaki, Takahashi, Toshiaki, Kasahara, Kazuo, Hattori, Yoshihiro, Ichihara, Eiki, Adachi, Noriaki, Noguchi, Kazuo, Souza, Fabricio, Kurata, Takayasu
Publicado 2021

Pembrolizumab in Asian patients with microsatellite‐instability‐high/mismatch‐repair‐deficient colorectal cancer

por Yoshino, Takayuki, Andre, Thierry, Kim, Tae Won, Yong, Wei Peng, Shiu, Kai‐Keen, Jensen, Benny Vittrup, Jensen, Lars Henrik, Punt, Cornelis J. A., Smith, Denis, Garcia‐Carbonero, Rocio, Alcaide‐Garcia, Julia, Gibbs, Peter, de la Fouchardiere, Christelle, Rivera, Fernando, Elez, Elena, Le, Dung T., Adachi, Noriaki, Fogelman, David, Marinello, Patricia, Diaz, Luis A.
Publicado 2022

Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non‐small‐cell lung cancer in KEYNOTE‐407

por Sugawara, Shunichi, Tanaka, Kentaro, Imamura, Fumio, Yamamoto, Nobuyuki, Nishio, Makoto, Okishio, Kyoichi, Hirashima, Tomonori, Tanaka, Hiroshi, Fukuhara, Tatsuro, Nakahara, Yasuharu, Kurata, Takayasu, Katakami, Nobuyuki, Okada, Morihito, Horinouchi, Hidehito, Udagawa, Hibiki, Kasahara, Kazuo, Satouchi, Miyako, Saka, Hideo, Tokito, Takaaki, Hosomi, Yukio, Aoe, Keisuke, Kishi, Kazuma, Ohashi, Kadoaki, Yokoyama, Takuma, Adachi, Noriaki, Noguchi, Kazuo, Schwarzenberger, Paul, Kato, Terufumi
Publicado 2023